Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
piotr wysocki
Mar 4, 2024, 17:27 |
Drugs
Piotr Wysocki: Anthracyclines must always be considered in the adjuvant treatment of breast cancer patients- final results of ABC trials
Piotr Wysocki, Professor of Medicine and Head of Department of Oncology at Jagiellonian University Hospital…
Dec 12, 2023, 17:44 |
Insight
Piotr Wysocki: SABCS2023 - Adjuvant chemoimmunotherapy does not benefit TNBC patients
Piotr Wysocki, Head of Department of Oncology at Jagiellonian University Hospital, shared on LinkedIn: "SABCS2023…
Dec 11, 2023, 18:39 |
Insight
Piotr Wysocki: Breast cancer patients may safely use vaginal estrogens
Piotr Wysocki, Head of Department of Oncology at Jagiellonian University Hospital, shared on LinkedIn: "Breast…
Nov 15, 2023, 19:26 |
Dialogues
OncoDaily Dialogues #2 - Piotr Wysocki / Hosted by Roupen Odabashian
We continue our series of “OncoDaily Dialogues”. This initiative by OncoDaily is designed to spotlight…
Apr 12, 2024, 10:05 |
Drugs
Piotr J. Wysocki: Immunotherapy combined with tyrosine-kinase inhibitor is not better than docetaxel in NSCLS patients after first-line chemoimmunotherapy failure
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Apr 12, 2024, 09:11 |
Opinion
Piotr J. Wysocki: PSA screening does reduce prostate cancer mortality, but the overall benefit is small, according to a secondary analysis of the CAP trial
Piotr J. Wysocki, Head of Department of Oncology at Jagiellonian University Hospital, shared a post…
Apr 5, 2024, 02:23 |
Insight
Piotr J. Wysocki: OPTICAL trial - another study demonstrating the feasibility and promising efficacy of neoadjuvant chemotherapy in locally advanced colon cancer
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Apr 5, 2024, 01:51 |
Insight
Piotr J. Wysocki: Pembrolizumab significantly improves efficacy of chemoradiotherapy in patients with locally-advanced cervical cancer
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Mar 30, 2024, 11:36 |
Insight
Piotr J. Wysocki: Pembrolizumab remains the only drug active in adjuvant settings in RCC – updated results of the ECOG-ACRIN E2810 on adjuvant pazopanib
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Mar 22, 2024, 23:32 |
Insight
Piotr J. Wysocki: Ribociclib combined with an aromatase inhibitor in the adjuvant treatment of breast cancer – interim analysis of Natalee study
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
7
8
9
10
11
All:
112
Posts:
81 - 90
Dikembe Mutombo: In Memory of Basketball Icon Who Died at 58 Battling Brain Cancer
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 7
César Milstein - The Father of Modern Immunology
ESTRO: Everything You Need to Know About European Society for Radiotherapy and Oncology
Jane Fonda Breast Cancer and Non-Hodgkin Lymphoma: How She Went Against, How She Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube